Altimmune (ALT) Asset Utilization Ratio (2011 - 2025)
Altimmune (ALT) reported Asset Utilization Ratio of 0.0 for Q4 2025, up 18.12% year-over-year from 0.0 in Q4 2024, and up 68.15% on a QoQ basis from 0.0 in Q3 2025.
Altimmune (ALT) has 15 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q4 2025.
- Quarterly Asset Utilization Ratio rose 18.12% year-over-year to 0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0 (up 18.12% YoY) and the FY2025 annual result came in at 0.0, up 71.12% from the prior year.
- Asset Utilization Ratio rose to 0.0 in Q4 2025 per ALT's latest filing, from 0.0 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.04 in Q1 2021 and bottomed at 0.0 in Q3 2025.
- The 5-year median for Asset Utilization Ratio is 0.0 (2023), against an average of 0.01.
- The widest annual swing landed in 2022, when Asset Utilization Ratio sank 98.37%; it then soared 661.51% in 2024.
- Tracing ALT's Asset Utilization Ratio over 5 years: stood at 0.02 in 2021, then slumped by 98.37% to 0.0 in 2022, then soared by 617.8% to 0.0 in 2023, then plunged by 93.83% to 0.0 in 2024, then rose by 18.12% to 0.0 in 2025.
- Per Business Quant, the three latest ALT Asset Utilization Ratio figures stand at 0.0 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.85 |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.02 |
| Mar 31, 2021 | 0.04 |
| Dec 31, 2020 | 0.05 |
| Sep 30, 2020 | 0.06 |
| Jun 30, 2020 | 0.10 |
| Mar 31, 2020 | 0.09 |
| Dec 31, 2019 | 0.11 |
| Sep 30, 2019 | 0.13 |
| Jun 30, 2019 | 0.15 |
| Mar 31, 2019 | 0.18 |
| Dec 31, 2018 | 0.19 |
| Sep 30, 2018 | 0.18 |
| Jun 30, 2018 | 0.20 |
| Mar 31, 2018 | 0.20 |
| Dec 31, 2017 | 0.14 |
| Sep 30, 2017 | 0.11 |
| Jun 30, 2017 | 0.08 |
| Mar 31, 2017 | 0.07 |
| Dec 31, 2016 | 0.03 |
| Sep 30, 2016 | 0.03 |
| Jun 30, 2016 | 0.17 |
| Mar 31, 2016 | 0.24 |
| Dec 31, 2015 | 0.52 |
| Sep 30, 2015 | 0.51 |
| Jun 30, 2015 | 0.46 |
| Mar 31, 2015 | 0.57 |
| Jun 30, 2014 | 0.98 |
| Mar 31, 2014 | 0.96 |
| Dec 31, 2013 | 0.95 |
| Sep 30, 2013 | 0.90 |
| Jun 30, 2013 | 1.01 |
| Mar 31, 2013 | 1.14 |
| Dec 31, 2012 | 1.09 |
| Sep 30, 2012 | 1.08 |
| Jun 30, 2012 | 0.99 |
| Mar 31, 2012 | 1.01 |
| Dec 31, 2011 | 1.09 |
| Sep 30, 2011 | 1.04 |